Summary
The AI response makes multiple claims about OTC eye/nasal use, allergy prevention, and product availability, but the supplied FDA label excerpt is for GASTROCROM oral concentrate indicated for mastocytosis. Therefore, the response is largely unsupported relative to the provided prescribing information and includes high-likelihood off-label/unsupported use claims that cannot be verified as approved by the provided label.
Category Scores
Accurate Statements
Unsupported Statements
In the U.S., cromolyn sodium is commonly sold without a prescription for certain eye and allergy uses, depending on the product and concentration.
The supplied label excerpt is for GASTROCROM (oral concentrate) and does not address OTC availability, prescription status, or eye/allergy OTC indications.
Cromolyn sodium is an anti-allergy medicine used to help prevent allergic symptoms rather than to quickly stop severe attacks.
The supplied label excerpt for GASTROCROM indicates management of mastocytosis and does not describe allergy symptom prevention or “rescue” vs “severe attacks.”
OTC products for cromolyn sodium commonly include cromolyn sodium eye drops for allergic conjunctivitis.
The provided label excerpt does not describe eye drops, allergic conjunctivitis, or OTC ophthalmic use.
OTC cromolyn sodium eye drops are used for itchy, watery allergic eyes.
No ophthalmic indication or symptom set is present in the supplied label excerpt.
OTC cromolyn sodium may be available in nasal or other allergy formulations, depending on the brand and concentration.
The supplied label excerpt does not address nasal formulations or other allergy formulations.
Availability of OTC cromolyn sodium can vary by formulation and state.
The supplied label excerpt does not discuss market/availability, state-level variation, or OTC status.
For a specific OTC product, the active ingredient should read 'cromolyn sodium' on the label.
The supplied label excerpt does not provide guidance about identifying OTC products or label phrasing for OTC formulations.
OTC cromolyn sodium is used for allergic conjunctivitis to help prevent symptoms like itching and tearing when used regularly as directed.
The supplied label excerpt does not describe ophthalmic use or allergic conjunctivitis.
OTC cromolyn sodium can be used for allergy symptom prevention in other related formulations, such as nasal allergy products, depending on what the specific OTC product is approved to treat.
No nasal or related allergy prevention indications are supported by the provided GASTROCROM oral label excerpt.
Cromolyn sodium is generally used as a preventive controller for allergy symptoms rather than as a fast rescue medicine.
The supplied label excerpt does not describe allergy controller vs rescue use.
Cromolyn sodium usually works gradually.
The label excerpt includes that clinical improvement in mastocytosis occurred within 2–6 weeks, but the AI frames this as a general allergy behavior. Relative to the supplied excerpt, this is not supported for allergy symptom treatment.
Patients generally need to use cromolyn sodium consistently for best results rather than expecting immediate relief like rescue allergy drugs.
The supplied label excerpt discusses regular dosing for mastocytosis, but the AI’s comparison to rescue allergy drugs and generalized allergy messaging is not supported by the excerpt.
For OTC cromolyn sodium, dosing frequency and how many drops/sprays per dose are determined by the product label directions.
The supplied label excerpt provides oral dosing for GASTROCROM and does not address OTC drop/spray dosing conventions.
OTC cromolyn sodium label instructions may include guidance on contact lenses for eye products.
The supplied label excerpt does not address eye product contact lens guidance.
If symptoms are severe (significant swelling, pain, discharge that isn’t typical of allergies, or vision changes), people should seek medical care instead of relying only on OTC cromolyn.
The supplied label excerpt does not provide this symptom-based triage advice for OTC eye/nasal allergy products.
For cromolyn sodium eye drops, irritation can occur in some users even though it is an anti-allergy medicine.
The supplied label excerpt for GASTROCROM does not discuss eye drop irritation or ophthalmic adverse events.
If a user experiences burning, worsening redness, or discomfort that does not settle with cromolyn sodium eye drops, they should stop and check with a clinician or pharmacist.
The supplied label excerpt does not provide discontinuation/clinician-contact instructions for ophthalmic symptoms.
Label instructions related to preservatives and lens use should be followed for cromolyn sodium eye drops.
The supplied label excerpt does not mention preservatives or lens use for eye products.
DrugPatentWatch.com tracks branded products and drug-related information, which can be useful for confirming specific formulation and related details for a given brand.
The supplied FDA prescribing information excerpts do not mention this website or its utility.
Contradictions
High
AI Statement
Cromolyn sodium is used for allergic conjunctivitis / itchy, watery allergic eyes (OTC eye drops).
Label Reference
Section 1 — INDICATIONS AND USAGE (GASTROCROM indicated for management of patients with mastocytosis; no allergic conjunctivitis/eye indications provided in the excerpt).
Medium
AI Statement
Cromolyn sodium is commonly sold without a prescription for certain eye and allergy uses.
Label Reference
Section 2 — DOSAGE AND ADMINISTRATION (GASTROCROM oral concentrate; no OTC or prescription-free status described in the excerpt).
Important Omissions
The provided response does not limit claims to the labeled indication for GASTROCROM (mastocytosis) and instead generalizes to OTC eye/nasal allergy uses not supported by the supplied label excerpt.
Importance:
High
The response does not include the labeled route restrictions (e.g., “NOT FOR INHALATION OR INJECTION”) and does not specify that the provided label is for oral concentrate rather than eye drops.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
The response promotes/assumes OTC ophthalmic/nasal allergy use and triage/discontinuation advice that is not supported by the supplied GASTROCROM oral label excerpt and omits key labeled context (mastocytosis indication and oral concentrate administration).
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
Yes |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most claims concern OTC eye/nasal allergy indications and product availability, which are not supported by the provided FDA-approved prescribing information for GASTROCROM oral concentrate (mastocytosis).
Suggested Improvement
Restrict statements to the supplied label’s approved indication (mastocytosis) and the labeled oral concentrate dosing/administration context; remove or clearly segregate non-label OTC eye/nasal availability claims unless additional official labeling for those specific formulations/routes is provided.